Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review

Immunocompromised individuals are at high risk of poor coronavirus disease 2019 (COVID-19) outcomes and demonstrate a lower immune response to COVID-19 vaccines, including to the novel mRNA vaccines that have been shown to elicit high neutralizing antibody levels. This review synthesized available d...

Descripción completa

Detalles Bibliográficos
Autores principales: Napuri, Norka I., Curcio, Daniel, Swerdlow, David L., Srivastava, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132351/
https://www.ncbi.nlm.nih.gov/pubmed/35614299
http://dx.doi.org/10.1007/s40121-022-00648-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132351/
https://www.ncbi.nlm.nih.gov/pubmed/35614299
http://dx.doi.org/10.1007/s40121-022-00648-2

Ejemplares similares